Intrexon Corp (XON) 24.00 $XON
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON
GlobeNewswire - Fri Jun 24, 11:18AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Intrexon Corporation ("Intrexon"
(NYSE:XON) securities between May 12, 2015 and April 20, 2016.
XON: 24.00 (-1.20)
FINAL NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jun 24, 11:13AM CDT
IRVINE, CA / ACCESSWIRE / June 24, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
XON: 24.00 (-1.20)
INTREXON DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Intrexon Corporation And Reminds Shareholders With Losses In Excess of $100,000 To Contact The Firm
ACCESSWIRE - Thu Jun 23, 5:44PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON) concerning possible violations of federal securities laws between May 12, 2015 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 5, 2016, lead plaintiff motion deadline.
XON: 24.00 (-1.20)
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Intrexon Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Thu Jun 23, 1:00PM CDT
Glancy Prongay & Murray LLP ("GPM" announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON) securities between May 12, 2015 and April 20, 2016, inclusive (the "Class Period". Intrexon investors have until July 5, 2016 to file a lead plaintiff motion.
XON: 24.00 (-1.20)
How These Biotech's Stocks are Performing? - Intrexon, Vertex Pharma, Arena Pharma, and Regeneron Pharma
PR Newswire - Thu Jun 23, 6:30AM CDT
The Biotechnology industry might still be in rough waters, but it continues to present great opportunities to investors. Stock-Callers.com assesses the recent performances of our featured companies for today: Intrexon Corp. (NYSE: XON), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Learn more about these stocks and receive your complimentary trade alerts at:
VRTX: 81.90 (-6.30), XON: 24.00 (-1.20), ARNA: 1.81 (-0.10), REGN: 339.48 (-17.66)
FINAL NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Intrexon Corporation And Advises Investors With Losses To Contact The Firm
ACCESSWIRE - Wed Jun 22, 5:52PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 22, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON) concerning possible violations of federal securities laws between May 12, 2015 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 6, 2016, lead plaintiff motion deadline.
XON: 24.00 (-1.20)
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Intrexon Corporation (XON) and Encourages Investors to Contact the Firm
BusinessWire - Wed Jun 22, 4:30PM CDT
Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who acquired Intrexon Corporation (NYSE:XON) securities between May 12, 2015 and April 20, 2016 (the "Class Period".
XON: 24.00 (-1.20)
Inovio Stock Up, Zika Vaccine Gets Nod for Phase I Study
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 3:51PM CDT
Inovio Pharmaceuticals (INO) and GeneOne Life Science will begin the first Zika vaccine study in human volunteers; Inovio's stock gains.
INO: 9.17 (-0.68), ANIP: 54.34 (-1.93), XON: 24.00 (-1.20), RTRX: 17.80 (-0.69)
INTREXON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Intrexon Corporation - XON
PR Newswire - Fri Jun 17, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Intrexon Corporation (NYSE: XON), if they purchased the Company's securities between May 12, 2015 and April 20, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Northern District of California.
XON: 24.00 (-1.20)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Intrexon Corporation (XON) and Lead Plaintiff Deadline: July 5, 2016
ACCESSWIRE - Fri Jun 17, 11:49AM CDT
NEW YORK / ACCESSWIRE / June 17, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Intrexon Corporation ("Intrexon" or "the Company" (NYSE: XON). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Horsehead securities between May 12, 2014 and April 20, 2016, both dates inclusive (the "Class Period".
XON: 24.00 (-1.20)
Fibrocell Announces Initiation of Patient Recruitment in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
GlobeNewswire - Mon Jun 13, 7:07AM CDT
Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs for diseases affecting the skin, connective tissue and joints, today announced the initiation of adult patient recruitment in its Phase I/II clinical trial of FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).
FCSC: 1.03 (+0.06), XON: 24.00 (-1.20)
INTREXON SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jun 10, 1:07PM CDT
IRVINE, CA / ACCESSWIRE / June 10, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
XON: 24.00 (-1.20)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Intrexon Corporation - XON
GlobeNewswire - Fri Jun 10, 12:18PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Intrexon Corporation securities (NYSE:XON) from May 12, 2015 through April 20, 2016, both dates inclusive (the "Class Period". The lawsuit seeks to recover damages for Intrexon investors under the federal securities laws.
XON: 24.00 (-1.20)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON
BusinessWire - Fri Jun 10, 11:14AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Intrexon Corporation ("Intrexon" (NYSE:XON) securities between May 12, 2015 and April 20, 2016.
XON: 24.00 (-1.20)
Intrexon to Present at the Jefferies 2016 Healthcare Conference
PR Newswire - Fri Jun 10, 7:00AM CDT
GERMANTOWN, Md., June 10, 2016 /PRNewswire/-- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announces Geno Germano, President of Intrexon, will present at the Jefferies Healthcare Conference at the Grand Hyatt in New York City today, Friday, June 10th at 11:30 a.m. Eastern Time.
XON: 24.00 (-1.20)
FINAL NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Intrexon Corporation And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Thu Jun 09, 4:04PM CDT
IRVINE, CA / ACCESSWIRE / June 9, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline.
XON: 24.00 (-1.20)
Oxitec Supports the National Academies of Sciences, Engineering, and Medicine Recommendations on Gene-drive and Highlights Why Oxitec's Self-limiting Approach is the Opposite of Gene-drive Method
PR Newswire Europe - Wed Jun 08, 4:07PM CDT
OXFORD, England, June 8, 2016 /PRNewswire/ --
XON: 24.00 (-1.20)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Intrexon Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Wed Jun 08, 1:57PM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON) securities between July 21, 2015 and January 13, 2016, inclusive (the "Class Period". Intrexon investors have until July 5, 2016 to file a lead plaintiff motion.
XON: 24.00 (-1.20)
INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON
GlobeNewswire - Fri Jun 24, 11:18AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Intrexon Corporation ("Intrexon"
(NYSE:XON) securities between May 12, 2015 and April 20, 2016. XON: 24.00 (-1.20)
FINAL NOTICE: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jun 24, 11:13AM CDT
IRVINE, CA / ACCESSWIRE / June 24, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. XON: 24.00 (-1.20)
INTREXON DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Intrexon Corporation And Reminds Shareholders With Losses In Excess of $100,000 To Contact The Firm
ACCESSWIRE - Thu Jun 23, 5:44PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 23, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company"
(NYSE: XON) concerning possible violations of federal securities laws between May 12, 2015 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 5, 2016, lead plaintiff motion deadline. XON: 24.00 (-1.20)
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Intrexon Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Thu Jun 23, 1:00PM CDT
Glancy Prongay & Murray LLP ("GPM"
announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON) securities between May 12, 2015 and April 20, 2016, inclusive (the "Class Period". Intrexon investors have until July 5, 2016 to file a lead plaintiff motion. XON: 24.00 (-1.20)
How These Biotech's Stocks are Performing? - Intrexon, Vertex Pharma, Arena Pharma, and Regeneron Pharma
PR Newswire - Thu Jun 23, 6:30AM CDT
The Biotechnology industry might still be in rough waters, but it continues to present great opportunities to investors. Stock-Callers.com assesses the recent performances of our featured companies for today: Intrexon Corp. (NYSE: XON), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Learn more about these stocks and receive your complimentary trade alerts at:
VRTX: 81.90 (-6.30), XON: 24.00 (-1.20), ARNA: 1.81 (-0.10), REGN: 339.48 (-17.66)
FINAL NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Intrexon Corporation And Advises Investors With Losses To Contact The Firm
ACCESSWIRE - Wed Jun 22, 5:52PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 22, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company"
(NYSE: XON) concerning possible violations of federal securities laws between May 12, 2015 and April 20, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 6, 2016, lead plaintiff motion deadline. XON: 24.00 (-1.20)
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Intrexon Corporation (XON) and Encourages Investors to Contact the Firm
BusinessWire - Wed Jun 22, 4:30PM CDT
Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who acquired Intrexon Corporation (NYSE:XON) securities between May 12, 2015 and April 20, 2016 (the "Class Period"
. XON: 24.00 (-1.20)
Inovio Stock Up, Zika Vaccine Gets Nod for Phase I Study
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 3:51PM CDT
Inovio Pharmaceuticals (INO) and GeneOne Life Science will begin the first Zika vaccine study in human volunteers; Inovio's stock gains.
INO: 9.17 (-0.68), ANIP: 54.34 (-1.93), XON: 24.00 (-1.20), RTRX: 17.80 (-0.69)
INTREXON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Intrexon Corporation - XON
PR Newswire - Fri Jun 17, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 5, 2016 to file lead plaintiff applications in a securities class action lawsuit against Intrexon Corporation (NYSE: XON), if they purchased the Company's securities between May 12, 2015 and April 20, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the Northern District of California. XON: 24.00 (-1.20)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against Intrexon Corporation (XON) and Lead Plaintiff Deadline: July 5, 2016
ACCESSWIRE - Fri Jun 17, 11:49AM CDT
NEW YORK / ACCESSWIRE / June 17, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Intrexon Corporation ("Intrexon" or "the Company"
(NYSE: XON). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Horsehead securities between May 12, 2014 and April 20, 2016, both dates inclusive (the "Class Period". XON: 24.00 (-1.20)
Fibrocell Announces Initiation of Patient Recruitment in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa
GlobeNewswire - Mon Jun 13, 7:07AM CDT
Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs for diseases affecting the skin, connective tissue and joints, today announced the initiation of adult patient recruitment in its Phase I/II clinical trial of FCX-007 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB).
FCSC: 1.03 (+0.06), XON: 24.00 (-1.20)
INTREXON SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Intrexon Corporation and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jun 10, 1:07PM CDT
IRVINE, CA / ACCESSWIRE / June 10, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. XON: 24.00 (-1.20)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Intrexon Corporation - XON
GlobeNewswire - Fri Jun 10, 12:18PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Intrexon Corporation securities (NYSE:XON) from May 12, 2015 through April 20, 2016, both dates inclusive (the "Class Period"
. The lawsuit seeks to recover damages for Intrexon investors under the federal securities laws. XON: 24.00 (-1.20)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Intrexon Corporation and a Lead Plaintiff Deadline of July 5, 2016 - XON
BusinessWire - Fri Jun 10, 11:14AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Intrexon Corporation ("Intrexon"
(NYSE:XON) securities between May 12, 2015 and April 20, 2016. XON: 24.00 (-1.20)
Intrexon to Present at the Jefferies 2016 Healthcare Conference
PR Newswire - Fri Jun 10, 7:00AM CDT
GERMANTOWN, Md., June 10, 2016 /PRNewswire/-- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announces Geno Germano, President of Intrexon, will present at the Jefferies Healthcare Conference at the Grand Hyatt in New York City today, Friday, June 10th at 11:30 a.m. Eastern Time.
XON: 24.00 (-1.20)
FINAL NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Intrexon Corporation And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Thu Jun 09, 4:04PM CDT
IRVINE, CA / ACCESSWIRE / June 9, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Intrexon Corporation ("Intrexon" or the "Company" (NYSE: XON). Investors who purchased or otherwise acquired shares between May 12, 2015 and April 20, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 5, 2016, lead plaintiff motion deadline. XON: 24.00 (-1.20)
Oxitec Supports the National Academies of Sciences, Engineering, and Medicine Recommendations on Gene-drive and Highlights Why Oxitec's Self-limiting Approach is the Opposite of Gene-drive Method
PR Newswire Europe - Wed Jun 08, 4:07PM CDT
OXFORD, England, June 8, 2016 /PRNewswire/ --
XON: 24.00 (-1.20)
The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Intrexon Corporation Investors and Encourages Investors to Contact the Firm
BusinessWire - Wed Jun 08, 1:57PM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Intrexon Corporation ("Intrexon" or the "Company"
(NYSE: XON) securities between July 21, 2015 and January 13, 2016, inclusive (the "Class Period". Intrexon investors have until July 5, 2016 to file a lead plaintiff motion. XON: 24.00 (-1.20)
